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Introduction
Retrograde transport from the endosomal compartments (late 
and early/recycling endosomes) to the TGN is implicated in 
diverse  cellular,  developmental,  and  pathological  processes 
(Johannes and Popoff, 2008). It is required for the transport of 
lysosomal acid hydrolases and the recycling of various mem-
brane proteins and signaling receptors. It is also involved in the 
transport of certain processing peptidases, SNAREs, and trans-
porters as well as bacteria and plant toxins (Bonifacino and   
Rojas, 2006). The delivery of Shiga toxin, cholera toxin, and 
ricin, for example, is dependent on this trafficking route. Simi-
larly, the recycling of the mannose 6–phosphate receptors 
(MPRs), the transmembrane peptidase furin, the TGN resident 
protein TGN38/46, the t-SNARE Stx6 (Syntaxin 6), and the   
v-SNARE VAMP4 also requires this transport route (Ghosh 
et al., 2003; Bonifacino and Rojas, 2006; Tran et al., 2007;   
Johannes and Popoff, 2008).
Numerous studies have shown that several distinct path-
ways mediate endosome-to-TGN transport (Sannerud et al., 2003;   
Pfeffer, 2009). These pathways use different Rab GTPases,   
tethering factors, and SNARE complexes. Transport from the 
late endosomes to the TGN is regulated by the Stx10–Stx16– 
Vti1a–VAMP3 SNARE complex and requires the Rab9 GTPase   
(Ganley et al., 2008), whereas transport from early/recycling   
endosomes to the TGN is mediated by the Stx6–Stx16–Vti1a– 
VAMP4  SNARE  complex  and  requires  the  Rab6A/Rab11   
GTPases (Mallard et al., 2002). The Stx5–GS28–Ykt6–GS15   
SNARE complex, which regulates intra-Golgi retrograde trans-
port, has also been implicated in retrograde transport from 
early/recycling endosomes to the Golgi complex (Mallard 
et al., 2002; Tai et al., 2004; Amessou et al., 2007). These 
SNARE complexes cooperate with multiple tethering factors,   
including the elongated coiled-coil tethers of the Golgin family:   
Golgin 97, Golgin 245, GCC185, and GCC88. It has been 
shown that Golgin 97, Golgin 245, and GCC185 are required 
T
he conserved oligomeric Golgi (COG) complex has 
been implicated in the regulation of endosome to 
trans-Golgi  network  (TGN)  retrograde  trafficking 
in both yeast and mammals. However, the exact mecha-
nisms by which it regulates this transport route remain 
largely unknown. In this paper, we show that COG inter-
acts directly with the target membrane SNARE (t-SNARE) 
Syntaxin 6 via the Cog6 subunit. In Cog6-depleted cells, 
the  steady-state  level  of  Syntaxin  6  was  markedly  re-
duced, and concomitantly, endosome-to-TGN retrograde 
traffic was significantly attenuated. Cog6 knockdown also   
affected the steady-state levels and/or subcellular distri-
butions of Syntaxin 16, Vti1a, and VAMP4 and impaired 
the assembly of the Syntaxin 6–Syntaxin16–Vti1a–VAMP4 
SNARE complex. Remarkably, overexpression of VAMP4, 
but not of Syntaxin 6, bypassed the requirement for COG 
and  restored  endosome-to-TGN  trafficking  in  Cog6- 
depleted  cells.  These  results  suggest  that  COG  directly 
interacts with specific t-SNAREs and positively regulates 
SNARE complex assembly, thereby affecting their associ-
ated trafficking steps.
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Mutations in the yeast COG complex impair the sorting of vac-
uolar  hydrolase  carboxypeptidase Y  and  the  retrieval  of  the   
v-SNARE Snc1p from the endosomal system back to the Golgi 
complex (Wuestehube et al., 1996; Spelbrink and Nothwehr, 
1999; Whyte and Munro, 2001). Likewise, depletion of certain 
COG subunits by RNAi in mammalian cells impairs endosome-
to-TGN retrograde transport of STx-B and of subtilase cyto-
toxin (Zolov and Lupashin, 2005; Sun et al., 2007; Smith et al., 
2009). These observations suggest that COG is involved in both 
intra-Golgi and endosome to Golgi retrograde transport. However, 
it remains unclear whether COG directly regulates endosome-
to-TGN traffic or indirectly influences this pathway as a result 
of its major effect on intra-Golgi retrograde transport.
Here, we show that COG directly and positively regu-
lates endosome-to-TGN retrograde transport by specific and 
direct interaction with the endosome-to-TGN fusion machin-
ery. We found that COG interacts directly with the t-SNARE 
Stx6 via its Cog6 subunit. In Cog6-depleted cells, endosome-
to-TGN retrograde transport of STx-B and TGN38 is markedly 
attenuated, and concomitantly, the steady-state distribution of 
TGN46, CI-MPR, and -adaptin is impaired. Cog6 knockdown 
(KD) also affects the steady-state distribution of Stx16, Vti1a, 
and VAMP4 and enhances their steady-state levels. In contrast, 
the steady-state level of the Stx6 protein is substantially reduced 
in Cog6-depleted cells, and its TGN localization is apparently   
abolished. Yet, overexpression of Stx6 fails to restore endosome-
to-TGN transport in Cog6-depleted cells. Overexpression of 
the  v-SNARE  VAMP4,  however,  bypasses  the  requirement 
for COG and restores both the TGN localization of Stx6 and   
endosome-to-TGN retrograde transport in Cog6-depleted cells. 
These results suggest that COG positively regulates both the 
stability and the recycling of Stx6, thereby affecting SNARE 
complex assembly at the TGN and, consequently, endosome-
to-TGN retrograde trafficking.
Results
Endosome-to-TGN retrograde transport is 
attenuated in Cog6-depleted cells
A previous study has shown that KD of the Cog3 subunit in 
mammalian cells substantially inhibited retrograde transport of 
STx-B to the Golgi complex (Zolov and Lupashin, 2005). To 
examine the influence of other COG subunits on the retrograde 
transport of STx-B, we depleted the expression of the Cog6 sub-
unit in HeLa cells by short hairpin RNAs (shRNAs; Fig. S1 A).   
As shown, KD of Cog6 distinctly affected the steady-state lev-
els of the different COG subunits (Fig. S1 B) but had minor 
effects on both the Golgi morphology and the Golgi localization 
of the first lobe’s subunits (Cog1–4; Fig. S1 C). However, it   
almost completely abrogated the Golgi localization of Cog5 
and Cog7 subunits and markedly attenuated both retrograde 
transport from the Golgi complex (Fig. S1, D and E) and retro-
grade transport of STx-B to the TGN. As shown in Fig. 1 A, 
the binding of STx-B to the cell surface at 4°C was unaffected 
by Cog6 depletion. However, 45 min after shifting the tempera-
ture to 37°C, STx-B was localized to the Golgi complex in the 
majority of the control cells (98%; n = 200) but could hardly 
for  efficient  retrograde  trafficking  of  the  Shiga  toxin  B  sub-
unit (STx-B), whereas GCC88 is required for the retrieval of 
TGN38/46 to the TGN (Luke et al., 2003; Yoshino et al., 2005; 
Lieu et al., 2007). The multisubunit tethering complex (MTC) 
Golgi-associated retrograde transport protein (GARP) complex 
is also essential for retrograde transport of STx-B as well as 
for the retrieval of TGN38/46 and the cation-independent (CI) 
MPR (Pérez-Victoria et al., 2008). This MTC is involved in the 
assembly of the Stx6–Stx16–Vti1a–VAMP4 SNARE complex, 
thereby regulating the fusion of endosome-derived vesicles with 
the  TGN  membrane  (Pérez-Victoria  and  Bonifacino,  2009). 
The conserved oligomeric Golgi (COG) complex has also been   
implicated in endosome-to-TGN retrograde transport.
COG is an evolutionally conserved Golgi-associated teth-
ering complex composed of eight subunits (Cog1–Cog8), which 
can be divided into two structurally and functionally distinct 
subcomplexes, lobe A (Cog1–4) and lobe B (Cog5–8) (Walter   
et al., 1998; Whyte and Munro, 2001; Ram et al., 2002; Ungar   
et al., 2002; Loh and Hong, 2004). Subunits of the first lobe are 
essential for cell growth in yeast and, therefore, are considered 
as  essential  components  of  the  complex  (Wuestehube  et  al., 
1996;  VanRheenen  et  al.,  1998;  Whyte  and  Munro,  2001).   
Mutations in the different COG subunits severely distress the 
Golgi glycosylation machinery and result in substantial altera-
tions in global cell surface glycoconjugates (Reddy and Krieger, 
1989; Wuestehube et al., 1996; Chatterton et al., 1999; Oka   
et al., 2005; Shestakova et al., 2006). The profound effect of 
COG on the Golgi glycosylation machinery and its association 
with congenital disorders of glycosylation in humans (Wu et al., 
2004; Foulquier et al., 2006, 2007; Kranz et al., 2007; Zeevaert 
et al., 2008) suggest that COG is involved in the transport, reten-
tion, and/or retrieval of Golgi glycosylation enzymes. Indeed, 
genetic and biochemical studies in yeast and mammalian cells 
suggest that COG functions as a tethering factor for vesicles that 
recycle within the Golgi apparatus, thereby regulating intra-Golgi 
retrograde transport and, consequently, the proper localization 
of Golgi glycosylation enzymes (Walter et al., 1998; Suvorova 
et al., 2001, 2002; Bruinsma et al., 2004; Ungar et al., 2006).
Like other MTCs, COG is thought to bridge the trans-
port vesicle with its target membrane through binding of Rab 
GTPases, SNAREs, and/or vesicle coats. Consistent with this 
mode of action, COG was found to interact directly with the 
small GTPase Ypt1p (Rab1), with the -COP subunit of the 
COPI coat complex, and with the Golgi t-SNARE Sed5/Stx5 
(Suvorova et al., 2002; Shestakova et al., 2007). COG interacts 
with Stx5 via its Cog4 subunit and appears to stabilize the intra-
Golgi Stx5–GS28–Ykt6–GS15 SNARE complex (Shestakova 
et al., 2007; Laufman et al., 2009). Previously, we found that 
COG also interacts directly with the SM (Sec1/Munc18-like) 
protein Sly1 via its Cog4 subunit and that the Cog4–Sly1 inter-
action is required for Stx5–GS28–Ykt6–GS15 SNARE com-
plex assembly and, consequently, for retrograde transport from 
the Golgi complex (Laufman et al., 2009).
In addition to its key role in intra-Golgi retrograde trans-
port (Suvorova et al., 2002; Bruinsma et al., 2004), COG was 
also proposed to tether vesicles that recycle to the Golgi complex 
from the endosomal compartments (VanRheenen et al., 1999). 461 COG in endosome-to-TGN transport • Laufman et al.
constitutively cycles between the TGN and the plasma mem-
brane via early/recycling endosomes (Ghosh et al., 1998). Control 
and Cog6-depleted HeLa cells expressing a HA-tagged TGN38 
were incubated with the anti-HA antibody for various periods 
of time, fixed, and double immunostained for TGN38-HA and 
either the TGN marker Golgin 97 or the early endosomal marker 
EEA1. As shown, TGN38-HA rapidly internalized into the cells 
and reached the Golgi complex of the control cells within 15–
30 min (Figs. 1 B and S2 B). At 30 min of antibody uptake, 
the colocalization between TGN38 and Golgin 97 reached to 
60 ± 15% in the control cells (n = 30). In contrast, only 15 ± 10%   
of  TGN38  fluorescence  was  colocalized  with  Golgin  97  in   
Cog6-depleted cells (n = 30), and instead, extensive colocaliza-
tion between TGN38 and EEA1 was detected (Fig. 1 B). These 
results suggest that the COG complex is essential for retrograde 
transport of both STx-B and TGN38/46 from early/recycling 
endosomes to the TGN.
be detected in the Golgi of Cog6-depleted cells (5%; n = 200). 
Instead, it was predominantly distributed in various punctate 
cytosolic structures (Fig. 1 A), which displayed weak colocal-
ization with the TGN marker Golgin 97 (11 ± 7% in Cog6-
depleted cells as compared with 66 ± 12% in control cells;   
n = 30). These structures were partially colocalized with the 
early endosomal marker EEA1 (Fig. S2 A), consistent with 
the transport of STx-B from the early/recycling endosomes to 
the TGN (Mallard et al., 1998). At 2 h after internalization, 
STx-B was localized mainly to the TGN of Cog6-depleted cells 
but could also be detected in punctate structures throughout the 
cytosol, suggesting that depletion of Cog6 markedly attenuates 
endosome-to-TGN trafficking of STx-B.
To further assess the effect of Cog6 KD on endosome-
to-TGN transport, we examined the trafficking of TGN38 from   
the cell surface to the TGN using an antibody uptake assay 
(Reaves et al., 1993). TGN38/46 is a resident TGN protein that 
Figure 1.  Endosome-to-TGN retrograde transport of STx-B and TGN38 is attenuated in Cog6-depleted cells. (A) Endosome-to-TGN transport of STx-B.   
Control (pSUPER-puro) and Cog6-depleted (KD) HeLa cells were incubated with recombinant purified His-tagged STx-B (1 µg/ml) for 30 min at 4°C and either 
fixed (Time 0) or transferred to 37°C for the indicated time periods. The cells were then fixed, double immunostained with anti-His (red) and anti–Golgin 97 
(Gol.97; green) antibodies, and analyzed by confocal microscopy. Shown are representative confocal images at the indicated time points. (B) Endosome-
to-TGN transport of HA-tagged TGN38. Control and Cog6-depleted HeLa cells expressing HA-TGN38 were incubated at 37°C with the anti-HA mono-
clonal antibody for various time periods (Fig. S2 B). The localizations of TGN38-HA (red) and Golgin 97 (green) were determined by immunostaining 
and confocal microscopy analysis. Shown are representative confocal images of control and Cog6-depleted cells at 3 and 30 min of antibody uptake.   
Bars: (A and B, main images) 10 µm; (B, zoom) 5 µm.JCB • VOLUME 194 • NUMBER 3 • 2011   462
was  localized  mainly  in  the  TGN,  consistent  with  previous   
studies (Bock et al., 1997; Klumperman et al., 1998; Wendler 
and Tooze, 2001). In Cog6-depleted cells, however, Stx6 lost 
its characteristic TGN localization and was observed in very 
faint cytosolic structures that could hardly be detected. These 
structures failed to colocalize with the early endosomal marker 
EEA1, suggesting that depletion of Cog6 affects the recycling 
of Stx6 to the TGN.
Next, we examined the effect of Cog6 KD on the steady-
state distribution of other SNAREs of the Stx6–Stx16–Vti1a–
VAMP4 SNARE complex. As shown in Fig. 3 B, the Golgi 
localization of Stx16 was markedly reduced in Cog6-depleted 
cells as compared with control HeLa cells. Yet, a residual Golgi 
staining of Stx16 could be observed. Depletion of Cog6 also 
impaired the Golgi localization of VAMP4, and it was mainly 
detected in various cytosolic structures. In contrast, Vti1a was 
localized to the Golgi of Cog6-depleted cells, similar to its loca-
tion in control cells. Nevertheless, Vti1a as well as Stx16 and 
VAMP4 lost their colocalization with Stx6, implying that de-
pletion of Cog6 impairs the assembly of the Stx6–Stx16–Vti1a–
VAMP4 SNARE complex. Collectively, these results suggest 
that Cog6 KD strikingly affects the steady-state distribution 
of Stx6 and also influences the distribution of its associated 
SNAREs. It is worth mentioning that Cog6 KD had no detect-
able effects on the Golgi localization of either Stx5 or GS28 
(Fig. S3). Yet, it abrogated the colocalization of GS15 with 
To confirm these transport assays results, we examined 
the steady-state distribution of various endogenous proteins that 
recycle between the early/recycling endosomes and the TGN, 
including the CI-MPR, TGN46, and -adaptin, a component 
of the AP-1 complex, which is required for endosome-to-TGN 
transport of MPRs (Meyer et al., 2000). As shown in Fig. 2, 
CI-MPR,  TGN46,  and  -adaptin  predominantly  localized  to 
the TGN of the control cells, consistent with previous studies 
(Reaves et al., 1993; Ghosh et al., 1998; Saint-Pol et al., 2004).   
Their  TGN  localization,  however,  was  markedly  reduced  in 
Cog6-depleted cells, and instead, they were predominantly seen 
in faint cytosolic structures. These results suggest that the traf-
ficking of endogenous CI-MPR, TGN46, and -adaptin from 
early/recycling endosomes to the Golgi apparatus is perturbed 
in the absence of an intact COG complex, and consequently, 
their Golgi localization is affected.
Depletion of Cog6 affects the TGN 
localization of Stx6 and its colocalization 
with Stx16, Vti1a, and VAMP4
The profound effect of Cog6 KD on the steady-state distribution 
of CI-MPR, TGN46, and -adaptin (Fig. 2) led us to examine its 
influence on the subcellular distributions of SNAREs that regu-
late endosome-to-TGN trafficking. The localization experiments 
shown in Fig. 3 A demonstrate the striking effect of Cog6 KD 
on the steady-state distribution of Stx6. In control cells, Stx6 
Figure 2.  Depletion of Cog6 impairs the Golgi localization of TGN46, CI-MPR, and -adaptin. (A and B) HeLa cells were transiently transfected with a 
Cog6 shRNA construct (A) or cotransfected with the Cog6 shRNA construct together with a vector encoding EGFP (B). 72 h later, the cells were fixed and 
double immunostained with an antibody against TGN46, CI-MPR, or -adaptin and either the anti-Cog6 antibody (A) or anti–Golgin 97 antibody (B). 
The TGN localization of TGN46, CI-MPR, or -adaptin was determined by colocalization with Golgin 97 (B). Cog6-depleted cells, which are marked by 
arrowheads, were identified either by immunostaining with the anti-Cog6 antibody (A) or by EGFP expression (B). Bars, 10 µm.463 COG in endosome-to-TGN transport • Laufman et al.
and light membrane fractions of the control cells. In contrast, it 
was highly enriched in the light membrane fraction (70%), 
which contains various vesicles, in Cog6-depleted cells. Its   
association with the heavy membrane fraction, containing the 
Golgi membranes, could hardly be detected in Cog6-depleted 
cells, consistent with the immunostaining results (Fig. 3 A) and 
its overall reduced steady-state level (Fig. 4 A). The distribution 
of Stx16, Vti1a, and VAMP4 was also affected by Cog6 KD, 
and these three SNARE proteins were enriched in the light 
membrane fraction compared with control cells (Fig. 4 C).   
A high level of Vti1a was also detected in the heavy membrane 
fraction of Cog6-depleted cells, which is consistent with its 
Golgi association shown in Fig. 3 B and its increased steady-
state level (Fig. 4 A). Collectively, these results show that KD 
of Cog6 enhances the association of all these SNAREs with 
vesicles or other light membranes but selectively reduces the 
steady-state level of Stx6.
This marked effect of Cog6 depletion on SNARE distri-
bution  could  affect  SNAREpin  assembly  and,  consequently, 
endosome-to-TGN retrograde transport. We therefore examined 
the effect of Cog6 KD on SNARE complex assembly by applying 
a  coimmunoprecipitation  assay.  Control  and  Cog6-depleted 
HeLa cells were treated with N-ethylmaleimide (NEM), which 
inhibits NSF, thereby preventing SNARE complex disassembly. 
Cells were then solubilized and subjected to immunoprecipi-
tation with the anti-Vti1a antibody. The association of Vti1a 
with Stx6, Stx16, and VAMP4 was determined by immunoblotting 
with the corresponding antibodies. As shown in Fig. 4 D, the four 
SNARE proteins could be detected in Vti1a immunocomplexes 
Stx5 (Fig. S3), consistent with the established role of COG in 
Stx5–GS28–Ykt6–GS15 SNARE complex assembly (Shestakova 
et al., 2007; Laufman et al., 2009).
Depletion of Cog6 affects the steady-state 
level and distribution of Stx6,  
its associated SNAREs, and SNARE 
complex assembly
To further confirm the immunostaining results shown in Fig. 3,   
we assessed the steady-state levels and the subcellular distri-
bution of Stx6, Stx16, Vti1a, and VAMP4 by Western blotting   
(Fig. 4 A) and by subcellular fractionation (Fig. 4 C), respectively. 
As shown in Fig. 4 A, a substantial decrease (50%) in the 
steady-state  level  of  Stx6  was  observed  in  Cog6-depleted 
cells, which is consistent with the faint immunostaining results   
(Fig. 3 A). In contrast, the steady-state levels of Vti1a, Stx16, 
and VAMP4 increased by 40–50%. Interestingly, the steady-
state level of the v-SNARE GS15 was also increased in Cog6-
depleted cells, whereas the levels of its associated t-SNAREs, 
Stx5,  GS28,  and Ykt6,  were  unaffected  by  Cog6  depletion   
(Fig. 4 B). These results suggest that depletion of Cog6 dis-
tinctly affects the steady-state levels of SNAREs of the Stx6–
Stx16–Vti1a–VAMP4 SNARE complex.
We next examined the subcellular distribution of these 
SNAREs by cell fractionation applying differential centrifuga-
tion.  Cell  homogenates  were  fractionated  into  heavy  mem-
branes, light membranes, and cytosol and analyzed by Western 
blotting and densitometry for SNARE distribution. As seen in 
Fig. 4 C, Stx6 was distributed almost equally between the heavy 
Figure 3.  The TGN localization of Stx6 and its colocalization with Stx16, Vti1a, and VAMP4 are abolished in Cog6-depleted cells. (A) The TGN localization 
of Stx6 (red) in Cog6-depleted cells (marked by arrowheads) was determined by colocalization with Golgin 97 (green; middle), whereas colocalization 
with EAA1 (green) was used to assess its localization on early endosomes (bottom). (B) The colocalization of Stx6 with Stx16 (green), Vti1a (green), 
or VAMP4 (red) was determined in control and Cog6-depleted (marked by arrowheads) cells. Bars, 10 µm.JCB • VOLUME 194 • NUMBER 3 • 2011   464
As shown, MG132 restored the level of Stx6 in Cog6-depleted 
cells, suggesting that Stx6 is abnormally degraded by the pro-
teasome in the absence of Cog6 subunit (Fig. 4 E). Interest-
ingly, KD of either the Cog4 or Cog8 subunits had no marked 
effect on the steady-state level of Stx6 (Fig. S4 A). Likewise,   
depletion of Cog6 had no detectable effects on the steady-state   
levels  of  other  cellular  components  that  regulate  endosome- 
to-TGN transport, including Golgin 97, Golgin 245, or the GARP 
subunits Vps52 and Vps53 (Fig. S4 B), suggesting that deple-
tion of Cog6 subunit selectively reduces the level of Stx6.
Cog6 interacts directly with the SNARE 
domain of Stx6 via its N-terminal  
coiled-coil domain
The profound and unique effect of Cog6 KD on the steady-state 
level of Stx6 implies that the presence of the Cog6 subunit is 
crucial for Stx6 stability. This could be explained, at least in 
part, by a physical interaction between these two proteins. We 
therefore  examined  whether  Cog6  interacts  with  Stx6  using 
of control cells, suggesting that SNARE complexes are assem-
bled and can be isolated by this method. However, Stx6 and 
VAMP4 could hardly be detected in the Vti1a immunocom-
plexes  of  Cog6-depleted  cells,  suggesting  that  KD  of  Cog6 
markedly affects the steady-state level of Stx6 and, conse-
quently, impairs the assembly of the Stx6–Stx16–Vti1a–VAMP4   
SNARE complex.
It was previously shown that depletion of different COG 
subunits affects the steady-state levels of a subset of type II 
Golgi  membrane  proteins  known  as  GEARs,  including  the 
Golgi SNAREs GS28 and GS15. These GEARS (GS28, GS15, 
GPP130, CASP, giantin, and Golgin 84) are mislocalized in 
COG-deficient  cells,  and  some  are  abnormally  degraded  by 
the proteasome (Oka et al., 2004, 2005). The marked effect of 
Cog6 KD on the steady-state level of Stx6 implies that it may 
also undergo abnormal proteasomal degradation. To explore 
this possibility, Cog6-depleted cells were treated with either the 
proteasome inhibitor MG132 or the lysosomal inhibitor chloro-
quine, and the level of Stx6 was examined by Western blotting. 
Figure  4.  Steady-state  levels,  subcellular  distribution,  and  SNARE  complex  assembly  of  Stx6,  Stx16,  Vti1a,  and  VAMP4  in  Cog6-depleted  cells.  
(A and B) The steady-state levels of SNAREs of either the Stx6–Stx16–Vti1a–VAMP4 SNARE complex (A) or the Stx5–GS28–Ykt6–GS15 SNARE complex (B)   
were determined by Western blotting of total cell lysates of control (pSUPER-puro) and Cog6-depleted HeLa cells using the corresponding antibodies. 
Densitometric analysis of the Western blot signals was used to estimate the relative level of each SNARE in Cog6-depleted cells as compared with the con-
trol HeLa cells. The mean values ± SD of three independent experiments are shown in the table. (C) The subcellular distribution of Stx6 and its associated 
SNAREs was determined by cell fractionation followed by Western blot analysis using the indicated antibodies. The distribution of each SNARE between 
the cytosol (Cyt.), heavy membrane (HM), and light membrane (LM) fractions in the control and Cog6-depleted HeLa cells is shown at the top. The relative 
distribution of each SNARE between the heavy and light membrane fractions was calculated from three independent experiments, and mean values ±   
SD are shown at the bottom. (D) SNARE complex assembly is impaired in Cog6-depleted cells. Control and Cog6-depleted HeLa cells were pretreated 
with NEM, solubilized, and subjected to immunoprecipitation (IP) with the anti-Vti1a antibody. The presence of Stx6, Stx16, and VAMP4 in the Vti1a   
immunocomplex was determined by immunoblotting (IB) using the corresponding antibodies. (E) Stx6 is degraded by the proteasome in Cog6-depleted 
cells. Cog6-depleted HeLa cells were treated with either the proteasome inhibitor MG132 (1 µM) or the lysosomal inhibitor chloroquine (10 µM) for 24 h. 
The level of Stx6 in control cells and in the inhibitor-treated Cog6-depleted cells was determined by Western blotting using the anti-Stx6 antibody. The table 
shows mean values ± SD. Molecular masses are indicated in kilodaltons. Exp., expression.465 COG in endosome-to-TGN transport • Laufman et al.
we coexpressed GFP-tagged Stx6 and the different COG sub-
units in HEK293 cells and assessed their interactions by co-
immunoprecipitation assay. The results shown in Fig. 5 B clearly 
demonstrate the strong interaction between Cog6 and Stx6.
To further characterize this interaction, we mapped the 
binding site of Stx6 in Cog6 using a set of Cog6-truncated mu-
tants. These mutants were prepared according to the predicted 
secondary structure of Cog6 and were expressed either as   
Myc-tagged proteins (Fig. 5 C) or GST fusion proteins (Fig. 5 D). 
GST pull-down experiments (Fig. 5 A). GST fusion proteins 
expressing the cytosolic domains of Stx6, Stx16, or Vti1a were 
purified  from  bacteria,  immobilized  on  glutathione-agarose 
beads, and incubated with lysates of HEK293 cells expressing 
each of the eight COG subunits. As seen, the Cog6 subunit 
strongly  interacted  with  Stx6.  No  detectable  interactions   
between Cog6 and Stx16, Vti1a (Fig. 5 A), VAMP3, VAMP4, 
or Stx10 (Fig. S5 A) were observed, suggesting that Cog6 selec-
tively interacts with Stx6. To further confirm these observations, 
Figure 5.  COG interacts with Stx6 via its Cog6 subunit. (A) Cog6 interacts with GST-Stx6. The cytosolic portions of Stx6, Stx16, and Vti1a were expressed 
in bacteria as GST fusion proteins and purified by glutathione-agarose beads (GB). Their ability to interact with the COG subunits was determined by the 
glutathione-agarose bead pull-down experiment using cell lysates of HEK293 cells expressing each of the eight COG subunits as a Myc-tagged protein. 
GST bound to glutathione-agarose beads was used as a negative control. The expression levels of the COG subunits are shown in the input control (10%), 
and those of the GST fusion proteins are shown at the bottom. (B) Cog6 coimmunoprecipitates with Stx6-GFP. The eight Myc-tagged COG subunits were 
coexpressed with GFP-fused Stx6 in HEK293 cells. Their interaction was determined by immunoprecipitation with the anti-Myc antibody and immuno-
blotting with the anti-GFP antibody. The expression levels of the COG subunits and Stx6-GFP are shown at the bottom. (C and D) Stx6 interacts with the N-terminal   
coiled-coil domain of Cog6. The indicated Cog6 truncated mutants were expressed either as Myc-tagged (C) or as GST fusion proteins (D) together with 
Stx6-GFP in HEK293 cells. Their interaction was determined either by immunoprecipitation with anti-Myc antibody and immunoblotting with anti-GFP 
antibody (C) or by glutathione-agarose bead pull-down followed by immunoblotting with the anti-GFP antibody (D). The expression levels of Stx6-GFP and 
Cog6 truncated mutants are shown at the bottom. The numbers indicate the aa residues. (E) Cog6 interacts with the SNARE domain of Stx6. GST fusion 
proteins expressing the indicated fragments of Stx6 were purified from bacteria, immobilized on glutathione-agarose beads, and incubated with the cell 
lysate of HEK293 cells expressing a Myc-tagged Cog6. 10% of this lysate (Input) was used for assessing the expression level of Myc-tagged Cog6. GST 
bound to glutathione-agarose beads was used as a control. The expression level of the different GST fusion proteins was determined by Coomassie blue 
staining and is shown on the right. The domain organization of Stx6 is shown in the attached scheme. TM, transmembrane. (F) Cog6 interacts directly with 
Stx6. Cog6 (aa 1–200) was expressed in bacteria as a GST fusion protein, immobilized on glutathione-agarose beads, and incubated with a recombinant 
His-tagged Stx6 (aa 1–234). The interaction between these recombinant proteins was determined by a glutathione-agarose bead pull-down experiment 
and, subsequently, by Western blotting using the anti-His antibody. GST was used as a control, and its expression level as well as the expression of GST-
Cog6 is shown on the right. (G) Endogenous COG interacts with endogenous Stx6. The HeLa cell lysate was subjected to immunoprecipitation (IP) with 
either the anti-Cog4 or anti-Cog6 antibody. Preimmune (P.I.) sera were used as controls. The presence of Stx6 in the immunocomplexes of the indicated 
COG subunits was determined by immunoblotting (IB) with the anti-Stx6 antibody. The interaction between the COG subunits was assessed by immuno-
blotting with the indicated anti-Cog antibodies. Molecular masses are indicated in kilodaltons.JCB • VOLUME 194 • NUMBER 3 • 2011   466
protein, whereas the N-terminal region of Cog6 (aa 1–200) was 
expressed as a GST fusion protein. The interaction between 
these recombinant proteins was assessed by a pull-down experi-
ment using GST-Cog6 (aa 1–200) immobilized on glutathione-
agarose beads. The results shown in Fig. 5 F strongly suggest 
that Stx6 interacts directly with Cog6.
We next examined the interaction between endogenous 
Cog6 and Stx6 by coimmunoprecipitation. As seen in Fig. 5 G, 
Stx6 was found in Cog6 immunocomplexes as expected but 
could also be detected in Cog4 immunocomplexes. These results 
suggest that the entire COG complex interacts with Stx6 via its 
Cog6 subunit.
Overexpression of VAMP4 restores  
the Golgi localization of Stx6 and 
endosome-to-TGN retrograde transport  
in Cog6-depleted cells
The remarkable effect of Cog6 KD on both the steady-state 
level and the subcellular distribution of Stx6 (Figs. 3 and 4) 
implies that the Cog6–Stx6 interaction is involved in both Stx6 
stabilization and its TGN localization. However, these two   
As shown in Fig. 5 C, a mutant containing the first 165 aa of 
Cog6 interacts strongly with Stx6, similar to the full-length 
Cog6. Further truncation narrowed down the binding site of Stx6 
to aa 81–165 (Fig. 5 D) at the N-terminal amphipathic helical 
region of Cog6 (Whyte and Munro, 2001, 2002). Collectively, 
these results suggest that Cog6 binds Stx6 via its N-terminal 
coiled-coil domain.
Next, we performed the reciprocal experiment and mapped 
the binding site of Cog6 in Stx6. Several Stx6 truncated mu-
tants were expressed as GST fusion proteins in bacteria, and 
their interaction with Cog6 was assessed by GST pull-down   
experiments. As shown in Fig. 5 E, Cog6 interacts with the 
entire cytoplasmic region of Stx6 (aa 1–234) as well as with 
its SNARE domain (aa 161–234) but fails to interact with the 
N-terminal region (aa 1–160) consisting of a trihelical bundle 
Habc domain and a flexible linker region. These results sug-
gest that Cog6 interacts with the SNARE domain of Stx6 via its   
N-terminal coiled-coil domain (aa 81–165).
To demonstrate that Cog6 interacts directly with Stx6, we 
used recombinant proteins expressed in bacteria. The cyto-
plasmic region of Stx6 (aa 1–234) was expressed as a His-tagged 
Figure 6.  VAMP4 rescues the TGN localization of Stx6 and endosome-to-TGN trafficking in Cog6-depleted cells. (A) Exogenous Stx6 failed to localize 
to the TGN of Cog6-depleted cells. Control (pSUPER-puro) and Cog6-depleted HeLa cells were transiently transfected with an expression vector encoding   
an HA-tagged Stx6. 24 h later, the cells were fixed and double immunostained with anti-HA and anti–Golgin 97 antibodies. The TGN localization of HA-Stx6 
was determined by colocalization with Golgin 97. Arrowheads mark cells expressing HA-Stx6. (B) Overexpression of VAMP4 restored the TGN localiza-
tion of Stx6 in Cog6-depleted cells. GFP-VAMP4 was overexpressed in Cog6-depleted HeLa cells, and 24 h later, the cells were fixed, immunostained 
with the anti-Stx6 antibody (red), and analyzed by confocal microscopy. Arrowheads mark the GFP-VAMP4–expressing cells. (C) VAMP4 overexpression 
restores endosome-to-TGN transport of STx-B in Cog6-depleted cells. Cog6-depleted HeLa cells were transiently transfected with an expression vector   
encoding GFP-VAMP4. 24 h later, the cells were incubated with recombinant His-tagged STx-B at 4°C for 30 min. The cells were then extensively washed, 
shifted to 37°C for 45 min, fixed, and double immunostained with anti-His and anti–Golgin 97 antibodies to mark the TGN. As shown, the localization 
of STx-B in the Golgi of Cog6-depleted cells was detected only in cells that overexpressed VAMP4-GFP, marked by arrowheads. (D) Overexpression of 
neither Stx6 nor GS15 rescued the endosome-to-TGN transport of STx-B in Cog6-depleted cells. Cog6-depleted HeLa cells were transiently transfected with 
HA-Stx6 or Myc-tagged GS15 and, 24 h later, incubated with His-tagged STx-B (1 µg/ml) for 30 min at 4°C. Shown are representative confocal images 
of STx-B localization after a 45-min incubation at 37°C. Cells expressing HA-Stx6 are marked by arrowheads. Bars, 10 µm.467 COG in endosome-to-TGN transport • Laufman et al.
of  Cog6-depleted  cells.  Overexpression  of  neither  Stx6  nor 
GS15 (Fig. 6 D) could restore retrograde transport of STx-B 
in Cog6-depleted cells. Collectively, these results suggest that 
COG plays two major roles: it is involved in the tethering of 
endosome-derived vesicles with the TGN membranes, thereby 
affecting the recycling of SNAREs to the TGN, promoting their 
assembly, and positively regulates endosome-to-TGN retrograde 
trafficking. In addition, it stabilizes Stx6 at the TGN via its di-
rect interaction with the Cog6 subunit, thereby stabilizing and/or 
promoting the assembly of a functional t-SNARE complex on 
the TGN, which provides a template for v-SNARE binding.
Discussion
In this study, we have identified a novel and direct interaction 
between the COG complex and the t-SNARE Stx6 and demon-
strated that this interaction is mediated by the Cog6 subunit 
(Fig. 5). In Cog6-depleted HeLa cells, the steady-state level 
of Stx6 was markedly reduced (Fig. 4 A), the assembly of the 
Stx6–Stx16–Vti1a–VAMP4  SNARE  complex  was  impaired 
(Fig. 4 D), and concomitantly, endosome-to-TGN retrograde 
traffic was substantially inhibited (Figs. 1 and 2). These results 
suggest that the Cog6–Stx6 interaction stabilizes Stx6, thereby 
affecting its steady-state level, SNARE complex assembly, and 
consequently, endosome-to-TGN transport. Consistent with this 
interpretation, we showed that Stx6 undergoes abnormal protea-
somal degradation in Cog6-depleted cells (Fig. 4 E) and that 
depletion of neither the Cog4 nor Cog8 subunit reduced the 
steady-state level of Stx6 (Fig. S4 A).
Abnormal proteasomal degradation of the Golgi SNAREs 
GS28 and GS15 was also observed in cells depleted of different 
COG subunits (Oka et al., 2004, 2005; Zolov and Lupashin, 2005; 
Laufman et al., 2009). However, a direct interaction between 
these SNAREs and the COG has not yet been identified. On 
the other hand, a direct interaction between certain SM proteins 
and t-SNAREs was found to stabilize their cognate t-SNAREs 
through a putative chaperone-like activity of SM proteins. Sly1, 
for example, interacts directly with the ER t-SNARE Ufe1p,   
a yeast homologue of Stx18, and protects it from ER-associated 
degradation (Braun and Jentsch, 2007). Likewise, the SM protein 
Vps45p interacts with Tlg2p, the yeast homologue of Stx16, 
and protects it from proteasomal degradation (Bryant and James, 
2001). Hence, it could be that Cog6 also induces conforma-
tional changes of its associated t-SNARE Stx6, thereby regulat-
ing its stability.
Nevertheless,  SM  proteins  generally  interact  with  the   
N-terminal regions of syntaxins (Südhof and Rothman, 2009), 
whereas Cog6 interacts with the SNARE domain of Stx6 (Fig. 5 E)   
via its N-terminal coiled-coil domain (aa 81–165) (Fig. 5 D). 
Interestingly, the N-terminal coiled-coil domain of Cog4 also 
interacts with the SNARE domain of Stx5 (Shestakova et al., 
2007), whereas the N-terminal coiled-coil domains of the 
Vps53 and Vps54 subunits of the mammalian GARP complex 
interact with the SNARE motifs of Stx6, Stx16, and VAMP4   
(Pérez-Victoria  and  Bonifacino,  2009).  These  N-terminal 
coiled-coil domains of GARP and COG subunits share sequence 
similarity with components of the exocyst complex (Whyte and 
potential roles could be interdependent. Degradation of Stx6 in 
the absence of Cog6 would reduce its total steady-state level 
and, consequently, affect its TGN localization. If this is indeed 
the case, stabilization of Stx6 should restore the TGN local-
ization of Stx6 in Cog6-depleted cells. To mimic a stabilized 
Stx6, we ectopically overexpressed it in Cog6-depleted cells 
and examined its subcellular localization. As shown in Fig. 6 A,   
HA-tagged Stx6 was mainly localized to the TGN of the control 
cells, consistent with the localization of the endogenous Stx6 
protein (Fig. 3 A). In contrast, it was localized mainly to various 
punctate cytosolic structures in Cog6-depleted cells and could 
hardly be detected in the TGN. These results are consistent with 
the effect of Cog6 KD on the distribution of endogenous Stx6 
and its enrichment in the light membrane fraction (Fig. 4 C). 
Yet, KD of Cog6 also affects the TGN localization of Stx16 
and VAMP4 (Fig. 3 B) and also induces their redistribution into 
the light membrane fraction (Fig. 4 C). These light membranes 
may represent endosome-derived transport vesicles that fail 
to tether with the TGN membranes. This possibility is consis-
tent with the role of COG as a tethering factor (Lupashin and   
Sztul, 2005) and the steady-state distribution of Stx6 and its   
associated  SNAREs  (Figs.  3  and  4).  Hence,  conditions  that 
could overcome the requirement for tethering might restore the 
recycling of Stx6 and its associated SNAREs and, consequently, 
their TGN localization in Cog6-depleted cells.
Previous  experiments  suggest  that  overexpression  of  a   
v-SNARE enhances its interaction with t-SNAREs on the target 
membranes by mass action, thereby bypassing the requirement 
for tethering factors (Pfeffer, 1996). Overexpression of the   
v-SNARE Bet1, for example, suppresses a temperature-sensitive 
mutation of the tethering factor Uso1p (Sapperstein et al., 1995, 
1996). Similarly, high-copy numbers of the v-SNARE Snc2p 
suppressed the temperature sensitivity of the sec35-1 strain, 
which carries a mutation in the Cog2 subunit (VanRheenen   
et al., 1998). We therefore examined whether overexpression   
of the v-SNARE VAMP4 could restore the TGN localization of 
Stx6 in Cog6-depleted cells.
Cog6-depleted  cells  were  transiently  transfected  with 
GFP-VAMP4, and the localization of Stx6 was examined by 
immunofluorescence  analysis.  As  seen  in  Fig.  6  B,  strong 
immunostaining of Stx6 was observed in the Golgi of Cog6- 
depleted cells overexpressing the GFP-VAMP4, and colocal-
ization between Stx6 and GFP-VAMP4 was detected. This   
effect was specific for VAMP4, as neither overexpression of 
the t-SNAREs Stx16 and Vti1a nor the v-SNARE GS15 could 
restore the TGN localization of Stx6 in Cog6-depleted cells 
(Fig. S5 B).
The  colocalization  between  GFP-VAMP4  and  Stx6   
(Fig.  6  B)  suggests  that  overexpression  of VAMP4  restored 
trans-SNARE complex assembly and, as a consequence, may 
also restore endosome-to-TGN retrograde trafficking. To explore 
this  possibility,  we  overexpressed  GFP-VAMP4  in  Cog6- 
depleted cells and examined its effect on endosome-to-TGN 
retrograde transport of STx-B. As shown in Fig. 6 C, over-
expression of GFP-VAMP4 rescued the effect of Cog6 KD on 
STx-B retrograde transport, and 45 min after internalization, 
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degradation. This could explain why the steady-state level of 
Stx6 is selectively reduced in Cog6-depleted cells despite the 
fact that all the other SNAREs are also enriched in intermediate 
transport elements (Fig. 4 C). Consistent with this dual role, 
we showed that overexpression of VAMP4 could bypass the 
requirement for COG (Fig. 6, B and C), suggesting that COG 
indeed functions as a tethering factor.
Previous experiments suggest that both tethering factors 
and SNAREs can contribute to vesicle docking and that over-
expression of SNAREs can compensate for tethering defects 
(Wiederkehr et al., 2004). Perhaps the most relevant example is 
related to the sec35 mutation, which can be bypassed by over-
expression of the v-SNARE protein Snc2p (VanRheenen et al., 
1998). Snc2p is very similar to Snc1p (Protopopov et al., 1993), 
the yeast homologue of VAMP3, and is functionally related to 
VAMP4 (Paumet et al., 2001). These genetic studies in yeast 
and the observations described in this study strongly suggest 
that COG is involved in the tethering of endosome-derived 
vesicles to the TGN membranes. Overexpression of VAMP4 
could bypass the requirement for COG because of the presence 
of multiple, locally concentrated v-SNARE proteins. These   
locally concentrated v-SNAREs could interact directly with the 
residual t-SNAREs (Stx16, Stx6, and Vti1a) on the TGN and, 
consequently, enable the fusion of endosome-derived vesicles. 
Over time, the fusion of these vesicles would restore the TGN 
localization  of  the  t-SNAREs  and,  consequently,  rescue  the 
transport defects. Collectively, our findings strongly suggest 
that COG is involved in both the stabilization of the t-SNARE 
complex at the TGN and in the tethering of endosome-derived 
vesicles with the TGN membranes, thereby affecting endosome-
to-TGN retrograde trafficking.
The capability of a given tethering factor, the COG, to 
regulate  both  intra-Golgi  and  endosome-to-TGN  retrograde 
transport, could provide a mechanism for coordination between 
the two trafficking pathways. These two transport routes must 
be tightly coordinated to maintain the structural and functional 
integrity of the Golgi complex. Although the Stx5–GS28–
Ykt6–GS15 SNARE complex has been implicated in the regu-
lation of both intra-Golgi and endosome to Golgi retrograde 
transport, we show here that overexpression of VAMP4, but not 
of GS15, could restore the endosome-to-TGN transport defect of 
STx-B in Cog6-depleted cells (Fig. 6, C and D). These results 
strongly suggest that the Stx6–Stx16–Vti1a–VAMP4 complex 
cooperates with COG in endosome-to-TGN trafficking, whereas 
the Stx5–GS28–Ykt6–GS15 SNARE complex cooperates with 
COG  in  intra-Golgi  retrograde  transport.  This  capability  of 
COG is mediated, at least in part, by direct interaction of COG 
subunits with different components of the fusion machinery: 
Cog4 interacts directly with Stx5 and Sly1 (Shestakova et al., 
2007; Laufman et al., 2009), whereas Cog6 interacts directly 
with Stx6. Whether other COG subunits interact directly with 
other components of the fusion machinery of these trafficking 
pathways is yet to be determined.
An important question emerging from our experiments is 
related to the multiple tethering factors that regulate endosome-
to-TGN transport and, in some cases, even use the same fusion 
machinery. It could be that multiple tethering factors are   
Munro, 2001, 2002) and may also share a common SNARE 
domain-binding capability.
Depletion of GARP subunits by RNAi impaired the re-
trieval of TGN46 as well as CI-MPR to the TGN and caused 
a redistribution of Stx16, VAMP4, and Vti1a from the TGN 
(Pérez-Victoria  and  Bonifacino,  2009;  Pérez-Victoria  et  al., 
2010). Similarly, KD of Cog6 had a profound effect on the 
steady-state distribution of these SNAREs (Figs. 2, 3, and 4 C)   
but also markedly affected their steady-state levels (Fig. 4,   
A and C). The effect of COG on the steady-state levels of these 
SNAREs seems to be unique, as it was not observed in response 
to KD of either GARP or GCC88 (Lieu et al., 2007; Pérez-Victoria 
and Bonifacino, 2009).
GCC88  does  not  interact  with  Stx6,  but  its  depletion 
dramatically perturbs the TGN localization of Stx6 without 
affecting either its steady-state level or the steady-state dis-
tribution of its associated SNAREs. Interestingly, overexpres-
sion of Stx6 in GCC88-depleted cells rescued the recycling of 
TGN38 (Lieu et al., 2007). The ability of exogenous Stx6 to 
rescue the transport defect of GCC88-depleted cells might be 
attributed to its proper TGN localization. Consistent with this 
possibility, exogenous Stx6 overexpressed in Cog6-depleted 
cells failed to localize to the TGN (Fig. 6 A) and, concomi-
tantly, could not restore the endosome-to-TGN transport de-
fects (Fig. 6 D). On the other hand, overexpression of VAMP4 
restored the TGN localization of Stx6 as well as endosome-to-
TGN trafficking (Fig. 6, B and C). These results demonstrate 
a direct link between the TGN localization of Stx6 and endosome-
to-TGN transport.
Yet, it is unclear why exogenous Stx6 failed to localize 
to the TGN of Cog6-depleted cells (Fig. 6 A). One potential 
explanation is that the direct interaction with Cog6 stabilizes its 
interactions with the other t-SNAREs on the TGN, thereby in-
fluencing its TGN localization. The interaction of Stx6 with the 
other t-SNAREs, especially with Stx16, appears to influence its 
TGN localization. A previous study has shown that depletion of 
Stx16 affects the TGN localization of Stx6 (Wang et al., 2005) 
and that exogenous Stx6 is properly localized to the TGN of 
GCC88-depleted cells. In these cells, the TGN localization of 
endogenous Stx16, Vti1a, or VAMP3/4 was unaffected (Lieu 
et al., 2007). In contrast, the TGN localization of Stx16 was 
markedly reduced in Cog6-depleted cells (Fig. 3 B), and con-
comitantly, exogenous Stx6 failed to localize to the TGN. This 
simple explanation may only partially explain the influence of 
Cog6 depletion on Stx6. Hence, we propose that COG plays 
two major roles that enhance each other. It affects the steady-
state level of Stx6 through a direct interaction with Cog6. This 
interaction  might  induce  conformational  changes  or  perhaps 
enables posttranslational modifications in the Stx6 protein. 
These modifications could stabilize Stx6 and/or its interactions 
with the other t-SNAREs on the TGN, thereby contributing to   
t-SNARE complex assembly. On the other hand, COG affects 
the recycling of the t-SNAREs to the TGN by its tethering activity. 
Thus, in the absence of Cog6, the recycling of the t-SNAREs   
to  the  TGN  is  impaired,  and  concomitantly,  the  ability  of   
Stx6 to interact with the other t-SNAREs is affected. Therefore, 
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used for PCR amplifications: Cog6 (aa 53–657), 5-AACGCACTCGA-
GATGTTAGAAGCTCTCAAGGC-3  and  5-AATGGTACCTCAGGAAA-
GAAGCGTCTGCAC-3; Cog6 (aa 1–165), 5-AAAGGATCCATGGCA-
GAGGGCAGCGGG-3 and 5-AAACTCGAGTCAAGAAGTCAGTTG-
GAACTTGG-3; Cog6 (aa 1–200), 5-AAACTCGAGATGGCAGAGGGC-
AGCGGG-3  and  5-CACGGTACCCTAACGCAAGAGAACTTTGAC-3; 
Cog6 (aa 201–657), 5-AAACTCGAGCGTACAAATCAACAAACGGC-3 
and 5-AATGGTACCTCAGGAAAGAAGCGTCTGCAC-3; Cog6 (aa 1–85), 
5-AAAGGATCCATGGCAGAGGGCAGCGGG-3  and  5-AAAGGTA-
CCTCAGGCTAAACTTTTACGTTCAATATCTCCACG-3;  and  Cog6  (aa 
81–165), 5-AAAGGATCCCGTAAAAGTTTAGCCATCAATGAAG-3 and 
5-AAACTCGAGTCAAGAAGTCAGTTGGAACTTGG-3.
The mammalian expression vector encoding the GFP-Stx6 was pro-
vided by J.E. Pessin (Stony Brook University, New York, NY). Mammalian 
expression vectors encoding the cytosolic fragments of the human Stx6, 
Stx16, and Vti1a were provided by S.R. Pfeffer (Stanford University School 
of  Medicine,  Stanford,  CA).  These  fragments  were  subcloned  into  the 
pGEX-4T-1 bacterial expression vector. The truncated Stx6 mutants were 
produced by subcloning of the corresponding PCR products into either 
pGEX-4T-1  or  pCDFDuet-1  bacterial  expression  vectors.  The  following 
sense and antisense primers have been used for PCR amplifications: Stx6 
(aa 1–160), 5-AGAGGATCCTCCATGGAGGACCCCTTCTTTG-3 and   
5-AAACTCGAGCTACTGTGCCTGCTGCTCCTCAATG-3; and Stx6 (aa 
161–234), 5-AACGGATCCCAGCAGCAGTTGATCGTGGAAC-3 and 
5-AAACTCGAGCTATTGGCGCCGATCACTGGTC-3.
The mammalian expression vector encoding GFP-VAMP4 has been 
previously described (Zeng et al., 2003). Truncated VAMP4 lacking its trans-
membrane domain was produced by PCR and subcloned into pGEX-4T-1. 
The  following  primers  were  used  for  PCR  amplification:  5-AACGGAT-
CCATGCCTCCCAAGTTCAAG-3  and  5-AGACTCGAGTCAGGCTTTTATT-
TTGCATCCAC-3. Mammalian expression vectors encoding HA-Stx16 
and  HA-Vti1a  were  provided  by  G.F.V.  Mollard  (Bielefeld  University, 
Bielefeld, Germany).
The cDNA of GS15 was PCR amplified from a mouse spleen cDNA 
library, sequenced, and subcloned into pCMV-neomycin-Myc mammalian 
expression vector. The following sense and antisense oligonucleotide   
primers were used: 5-AAAGGATCCTATGGCGGACTGGGCTCGG-3 
and 5-AAACTCGAGTCACGTCCTTGCCCTGGAC-3.
shRNA  constructs.  The  mammalian  pSUPER-puro  vector  was  used 
for expression of shRNAs corresponding to nucleotides 1,242–1,260   
(5-GGAGCTAATTGGCTTATAT-3) of the human Cog4 cDNA and nucleo-
tides 1,512–1,531 (5-GACCTTGTTCCGTATTTAA-3) of the human Cog8 
cDNA. Two shRNAs have been used to knock down the expression of   
Cog6 shRNA1 and shRNA2 corresponding to nucleotides 1,591–1,609   
(5-GCACATTTGGACACACTTA-3) and 348–366 (5-AGATATGACAA-
GTCGCCTA-3) of the human Cog6 cDNA, respectively. shRNA1 has been 
chosen for further analysis shown in the figures in this paper.
Cell culture, transfection, and immunofluorescence microscopy
HEK293 and HeLa cells were grown in DME supplemented with 10% fetal 
bovine serum, 100 µg/ml penicillin, and 100 µg/ml streptomycin. The 
cells were transfected using either the calcium-phosphate method or trans-
fection reagent (FuGENE HD; Roche). Stable HeLa cell lines depleted of the 
Cog6 subunit were established using the pSUPER-puro vector encoding 
shRNA1  (nucleotides  1,591–1,609)  as  previously  described  for  Cog4 
(Laufman  et  al.,  2009).  A  stable  HeLa  cell  line  harboring  an  empty   
pSUPER-puro vector was established and used as a control. These stable 
HeLa cell lines were used in all the transport assays and rescue experi-
ments described in this paper (Figs. 1 and 6). Transient transfections with 
the Cog6 shRNA1 construct or the pSUPER-puro empty vector were per-
formed for all the localization experiments and the biochemical analysis. 
In brief, HeLa cells grown on coverslips or in 90-mm tissue culture dishes 
were transiently transfected with the Cog6 shRNA1 construct or pSUPER-
puro vector using FuGENE HD. 24 h after transfection, the cells were   
either incubated with regular medium for 72 h and then analyzed by   
immunofluorescence or were incubated with 1 µg/ml puromycin for 72 h 
and then analyzed by the indicated biochemical assay as described in the 
legends of Figs. 4, S1, and S4.
For immunofluorescence analysis, control and Cog6-depleted HeLa 
cells were grown on coverslips, washed with PBS, and fixed in 1% para-
formaldehyde in either PBS or KM buffer (10 mM 2-(N-morpholino)ethanes
ulfonic acid, pH 6.2, 10 mM NaCl, 1.5 mM MgCl2, and 2.5% glycerol) 
for 20 min at room temperature. Fixed cells were then permeabilized with 
either 0.1% Triton X-100 or 0.03% saponin (VAMP4 staining) in PBS and 
immunostained at room temperature essentially as previously described 
required for efficient recycling of SNAREs that regulate this 
transport route. Components of the Stx6–Stx16–Vti1a–VAMP4 
SNARE complex are involved in different transport steps and 
are assembled into different SNARE complexes. VAMP4, for 
example, is a multifunctional v-SNARE that is required in the 
endocytic pathway as well as for the fusion of secretory vesicles 
with the plasma membrane (McNew et al., 2000; Hong, 2005). 
Similarly, Stx6 appears to take part in a variety of membrane 
fusion events as part of different SNARE complexes (Wendler 
and Tooze, 2001). Hence, multiple tethering factors could provide 
overlapping backup mechanisms that ensure efficient recycling 
of these SNAREs, thereby contributing to the coordination of 
distinct fusion events. Consistent with this role, KD of either 
GARP, GCC88, GCC185, or COG, as shown here, attenuates 
rather than abolishes endosome-to-TGN transport of certain 
cargoes. Yet, it could be that different tethering factors are re-
sponsible for the transport of different cargoes using the same 
SNARE complex. Identification of additional cargo molecules 
that use this trafficking route and elucidating the mechanisms 
by which different tethering factors regulate their transport 
would greatly contribute to the current understanding of fusion 
events at the TGN.
Materials and methods
Antibodies, reagents, and chemicals
Polyclonal antibodies against Cog3, Cog4, Cog7, and Golgin 97 as well 
as  the  monoclonal  antibody  against  GS28  were  previously  described 
(Subramaniam et al., 1995; Lu et al., 2004; Laufman et al., 2009). Poly-
clonal  antibodies  against  Cog2  (aa  500–578),  Cog6  (aa  103–230), 
and Stx6 (aa 1–235) were raised in rabbits immunized with recombi-
nant GST fusion proteins consisting of the indicated aa residues. Poly-
clonal antibodies against Cog5 and Cog8 were provided by D. Ungar 
(York University, York, England, UK), and a polyclonal antibody against 
Cog1 was provided by M. Krieger (Massachusetts Institute of Technology,   
Cambridge, MA). Polyclonal antibodies against Stx16 and Stx5 were a 
gift from B.L. Tang (National University of Singapore, Singapore) and from   
Z. Elazar (Weizmann Institute of Science, Rehovot, Israel), respectively. 
Polyclonal  anti-VAMP4  and  anti-Vti1a  antibodies  were  purchased  from   
Synaptic Systems and from Proteintech Group, Inc., respectively. Monoclonal   
anti-GS15,  anti-Stx6,  anti-EEA1,  and  anti–-adaptin  antibodies  were 
purchased  from  BD.  Monoclonal  anti–CI-MPR  and  anti-His  antibodies 
and polyclonal anti-EEA1 and anti–CI-MPR antibodies were purchased 
from  Abcam.  The  sheep  anti-TGN46  antibody  was  purchased  from 
AbD  Serotec.  The  monoclonal  anti–KDEL  receptor  (KDELR)  antibody 
was obtained from Santa Cruz Biotechnology, Inc., and the polyclonal 
anti–mannosidase II antibody was obtained from the University of Geor-
gia. Polyclonal antibodies against Vps52 and Vps53 and the polyclonal 
anti-Arf1 antibody were provided by J. Bonifacino (National Institutes of 
Health, Bethesda, MD) and by B. Aroeti (Hebrew University, Jerusalem, 
Israel), respectively. The mouse anti–-tubulin antibody was purchased 
from Sigma-Aldrich. Alexa Fluor 488 donkey anti–mouse and anti–rabbit 
IgGs were purchased from Invitrogen. Cy3 (cyanine 3)-conjugated goat 
anti–rabbit and goat anti–mouse IgGs as well as the Cy5-conjugated 
goat  anti–rabbit  IgG  were  purchased  from  Jackson  ImmunoResearch 
Laboratories, Inc.
Protein  A–agarose  beads  were  purchased  from  Repligen  Corp.   
Ni-nitrilotriacetic  acid  agarose  beads  were  obtained  from  QIAGEN, 
whereas  the  anti–mouse  IgG  conjugated  to  agarose  beads,  Hoechst 
33342, MG132, and chloroquine was purchased from Sigma-Aldrich.
DNA constructs
The DNA constructs encoding the different Myc-tagged COG subunits have 
been described previously (Loh and Hong, 2002, 2004). Truncated Cog6 
mutants were produced by subcloning of the corresponding PCR products 
into either the pCMV-neomycin-Myc and the mammalian GST expression 
vectors or the pGEX-4T-1 bacterial expression vector, as indicated in the 
legend of Fig. 5. The following sense and antisense primers have been JCB • VOLUME 194 • NUMBER 3 • 2011   470
previously described (Laufman et al., 2009). In brief, control and Cog6-
depleted HeLa stable cell lines were either treated with 5 µg/ml BFA or 
incubated at 15°C for the indicated time points. The cells were then fixed, 
immunostained with anti–mannosidase II or anti-KDELR antibodies, respec-
tively, and analyzed by confocal microscopy.
Shiga toxin transport assay. The bacterial expression vector pCRT7 
(Invitrogen) encoding the His-tagged STx-B was a gift from D.B. Haslam 
(Washington University School of Medicine, St. Louis, MO). Recombinant 
STx-B  was  isolated  from  periplasmic  extracts  of  Escherichia  coli  BL21 
(pLysS) cells (Invitrogen). The cells were grown at 37°C in Luria-Bertani 
broth to an optical density of 0.6 at 600 nm and then were grown for an 
additional 2 h in the presence of 1 mM isopropylthiogalactoside. Periplas-
mic extraction was performed by osmotic shock, and the recombinant pro-
tein  was  purified  on  a  nickel  column  according  to  the  manufacturer’s 
instructions (QIAGEN). Control and Cog6-depleted HeLa stable cell lines 
were incubated in DME containing 20 mM Hepes, pH 7.4, and 1 µg/ml 
purified recombinant STx-B protein for 30 min at 4°C. The cells were then 
washed with PBS and incubated in a complete growth media at 37°C for 
the indicated time periods as described in Fig. 1 A. Cells were then fixed, 
double immunostained with anti-His and anti–Golgin 97 antibodies or with 
anti-His and anti-EEA1 antibodies, and analyzed by confocal microscopy.
Antibody uptake assay. Control and Cog6-depleted HeLa stable cell 
lines were transfected with a mammalian expression vector encoding 
HA-TGN38. 48 h later, the cells were incubated at 37°C in medium containing 
1.5 µg/ml anti-HA monoclonal antibody for the different time periods (3, 15, 
and 30 min and 1 and 2 h). The cells were then extensively washed with PBS, 
fixed, and stained with rabbit anti–Golgin 97 antibodies followed by staining 
with Cy3 anti–mouse and Alexa Fluor anti–rabbit secondary antibodies.
Quantitative analysis of transport assays. Confocal images of arbitrary 
fields from two independent experiments were acquired for both control and 
Cog6-depleted HeLa cells (n = 200–300, as indicated in the Results and in the 
legend of Fig. S2) using the LSM 510 software. The images were scored visu-
ally, and colocalization between the TGN marker Golgin 97 (Fig. 1 A, green) 
and either STx-B (Fig. 1 A, red) or TGN38 (Fig. 1 A, red) in the Golgi region 
was displayed as yellow in the merged image. Cells with a yellow signal in 
the Golgi were counted as positive. The percentage of cells exhibiting TGN-
localized TGN38 or STx-B is shown in Fig. S2 B or described in the results 
of Fig. 1 A, respectively. For precise quantitation of TGN localization, the 
colocalization between Golgin 97 and either STx-B or TGN38 was measured 
using the colocalization function of the LSM 510 software. Colocalization was 
determined by measuring the ratio between Golgi-associated STx-B or Golgi-
associated TGN38 fluorescence (marked by Golgin 97) to their total fluores-
cence in the cell. The data shown are mean values ± SD (n = 30).
Online supplemental material
Fig. S1 shows that depletion of the Cog6 subunit by shRNA affects the 
steady-state levels and the Golgi localization of COG subunits and attenu-
ates retrograde transport from the Golgi complex. Fig. S2 shows that deple-
tion of the Cog6 subunit affects retrograde transport of STx-B and TGN38 to 
the TGN. Fig. S3 shows that depletion of Cog6 has no effect on the Golgi 
localization of Stx5 and GS28. Fig. S4 shows that depletion of either Cog4 
or Cog8 subunits has no marked effect on the steady-state level of Stx6 and 
that depletion of the Cog6 subunit has no effect on the steady-state levels 
of cellular regulators of endosome-to-TGN trafficking. Fig. S5 shows that 
Cog6 does not interact with VAMP3, VAMP4, or Stx10 and that over-
expression of Stx16, Vti1a, or GS15 failed to restore the TGN localization 
of Stx6 in Cog6-depleted cells. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.201102045/DC1.
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